Malden, MA, United States of America

Amir Aref

USPTO Granted Patents = 4 

Average Co-Inventor Count = 5.0

ph-index = 2

Forward Citations = 6(Granted Patents)


Location History:

  • Malden, MA (US) (2019 - 2021)
  • Chestnut Hill, MA (US) (2023)

Company Filing History:


Years Active: 2019-2024

Loading Chart...
4 patents (USPTO):Explore Patents

Title: Amir Aref: Innovator in Tumor Cell Evaluation

Introduction

Amir Aref is a notable inventor based in Malden, MA (US). He has made significant contributions to the field of cancer research, particularly in the evaluation of tumor cell spheroids. With a total of 4 patents, his work focuses on innovative methods that enhance the understanding of tumor behavior and treatment efficacy.

Latest Patents

One of Amir Aref's latest patents is titled "Methods for evaluating tumor cell spheroids using 3D microfluidic cell culture device." This patent outlines methods for assessing tumor cell spheroids in a three-dimensional microfluidic device. The methods involve determining changes in the relative levels of live and dead cells in aliquots cultured under various conditions. Additionally, these methods facilitate the ex vivo recapitulation of the tumor microenvironment, allowing for predictions regarding the in vivo effectiveness of test compounds in treating tumor tissue.

Career Highlights

Amir Aref is currently associated with the Dana-Farber Cancer Institute Inc., where he continues to advance his research in cancer treatment methodologies. His work is pivotal in bridging the gap between laboratory research and clinical applications.

Collaborations

Amir collaborates with esteemed colleagues such as David Barbie and Russell W. Jenkins, contributing to a dynamic research environment focused on cancer innovation.

Conclusion

Amir Aref's innovative approaches in evaluating tumor cell spheroids represent a significant advancement in cancer research. His contributions are vital for improving treatment strategies and understanding tumor biology.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…